×
戻る Agenda
SS02: Preparations for Unexpected Infections from the COVID- 19 Pandemic:Rapid Development and Supply of Vaccines and Drugs for Patients
Session Chair(s)
Akiko Ikeda, RPH
Regulatory affairs, T Cell Noveau Inc., Japan
Mari Ariyasu
Head of Project Management 4, Senior Director, Shionogi & Co., Ltd., Japan
Speaker(s)
Kazuhiro Tateda, MD, PHD
Professor, Department of Microbiology and Infectious Diseases, Toho University, Japan
Noriko Morikubo
Regulatory Strategy Group2, Japan Regulatory Portfolio Lead, Pfizer R&D Japan G.K., Japan
Satoshi Aida
Chief Planner, Strategic Planning Department, Teijin Pharma Limited, Japan